ConductScience.org, home

Paper1900256

Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions?

Di Bisceglie AM and 1 other. Hepatology, 1991. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions? Papers, record 1900256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1900256

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions?
PubMed
Journal
Hepatology
PubMed
Year
1991
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2019-08-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Di Bisceglie AMA M
2Hoofnagle JHJ H

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis CMajor topic
Interferon Type IMajor topic
Clinical Trials as Topic
Contraindications
Humans
Randomized Controlled Trials as Topic

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on1900254Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.https://conductscience.org/library/papers/1900254

Source PubMed

Download CSV of comments and corrections

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
18370481Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C.Clin Drug Investig1998https://conductscience.org/library/papers/18370481PubMed
16482233Treatment outcomes in a centralized specialty clinic for hepatitis C virus are comparable with those from clinical trials.Can J Gastroenterol2006https://conductscience.org/library/papers/16482233PubMed
8601375IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.Dig Dis Sci1996https://conductscience.org/library/papers/8601375PubMed
8523531Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.J Virol1996https://conductscience.org/library/papers/8523531PubMed
8359618Alpha-interferon 2b in the treatment of chronic hepatitis C: interim report of the first multicentre Australian trial.Gastroenterol Jpn1993https://conductscience.org/library/papers/8359618PubMed
7904252Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.Gut1993https://conductscience.org/library/papers/7904252PubMed
7698703Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha.Gut1995https://conductscience.org/library/papers/7698703PubMed
7683189Chronic non-A, non-B hepatitis: role of hepatitis C virus.Arch Dis Child1993https://conductscience.org/library/papers/7683189PubMed
7512163An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.J Virol1994https://conductscience.org/library/papers/7512163PubMed
1576586Antiviral therapy: current concepts and practices.Clin Microbiol Rev1992https://conductscience.org/library/papers/1576586PubMed
1376366Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.J Virol1992https://conductscience.org/library/papers/1376366PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1900256

GET https://conductscience.org/api/papers/v1/1900256/authors